Specsavers Clinical Conference 8
Date: 7/09/2019 - 8/09/2019
Venue: Melbourne Convention and Exhibition Centre, Convention Centre Place, South Wharf, VIC, 3006
Provider: Specsavers Pty Ltd
Contact: Linda Keir, [E] anz.cpd@specsavers.com, [P] (03) 8532 8510
Learning Objectives
- To review the ways data-led interventions are improving optometry workforce delivery of eyecare
- To explore evidence-based optometry interventions that support lowering avoidable blindness rates
- To understand the importance of national screening programs in enabling optometry to improve patient outcomes in future
- To review clinical presentations of common paediatric conditions
- To review diagnostic workup of these conditions, and understand what can and can't be easily done in a standard optometric clinic
- To understand the place of optometric management of refractive and oculomotor paediatric conditions
- To review diagnosis of glaucoma and when to treat, and the appropriate modalities and first line therapies.
- To identify the role of OCT in management of glaucoma.
- To introduce modern approaches to glaucoma, moving from traditional surgery to MIGs or minimally invasive glaucoma surgery
- To recognise signs and symptoms of vitreoretinal emergencies
- To understand appropriate referral timelines for emergency and non-emergency conditions
- To consider appropriate follow-up and review periods for vitreoretinal conditions
- To be able to accurately assess and diagnose dry eye severity
- To review the available therapeutic treatment options for contact lens keratitis
- To understand refractive surgery options and suitability criteria and exclusion criteria
- To review and understand the principles of diabetic retinopathy screening programs
- To gain insight into the United Kingdom's successful approach to screening for diabetic retinopathy
- To understand what elements of the UK approach could be translated to Australian practice, and the impact this could have on avoidable blindness in Australia
- To understand the current and projected healthcare burden caused by diabetes and diabetic retinopathy
- To consider the role of optometry in a system-wide healthcare approach to reducing the burden caused by diabetes
- To recognise the benefits of a multi-disciplinary monitoring and recall system (KeepSight) in preventing avoidable blindness
- To review the RANZCO referral pathways for glaucoma
- To further investigate co-management of glaucoma between ophthalmologists and optometrists
- To understand the benefit of specialist –led training in creating and strengthening referral and co- management networks
- To review the pathophysiology of pigmented ocular lesions
- To be able to assess pigmented ocular lesions and develop differential diagnoses
- To understand referral criteria and urgencies for pigmented lesions
- To be able to recognise characteristic OCT findings in Diabetes & AMD
- To review classification and grading of diabetic retinopathy and AMD
- To understand and be able to follow the RANZCO referral pathways for AMD and diabetic retinopathy
- To understand presenting signs of ocular inflammation
- To review the use of ocular therapeutics in treating anterior inflammatory conditions
- To gain insight into the current best practice for managing acute inflammation
- To understand the support needs of patients – what patients want and need
- To understand the principles of collective impact for better patient outcomes
- To explore technology as an enabler of greater collaboration and partnership between Specsavers optometrists and MDFA
- Understand the low vision and blind services available to patients with vision impairment and blindness and be able to discuss these options with patients
- Appreciate how low vision technology is applied based on a patients individual needs
- Know when your vision impaired and blind patients need to be referred for specialised services
- To understand collaborative optometric management and therapeutics for glaucoma
- To identify the impact of Specsaver Optometrists driving the newly diagnosed glaucoma patients towards Glaucoma Australia using Oculo at the earliest convenience
- Key messages Glaucoma Australia promotes to those with glaucoma, their families and the general community
- To provide up to date data regarding current and forecast trends in diabetes
- To provide an overview of diabetes and how it relates to eye health
- To provide insight into the development of KeepSight, a national diabetes eye screening program
Max points awarded: 35.00
Session Information
| Name |
|---|
| Day 2: Transforming Eye Health |
| Activity Type |
|---|
| Face to Face without Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Day 2: Diabetic Retinopathy Screening |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 2: Diabetic Retinopathy Screening |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 1: Optometric management of paediatric conditions |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 2: Glaucoma co-management and the Ophthalmology Local Education and Engagement Program |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 1: Glaucoma diagnosis and management |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 2: Decoding the Alphabet Soup of Ocular Oncology |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 1: Adaptive Technology and Low Vision Patients |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Day 1: Integrated patient support for patients at risk or living with macular disease |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Day 2: How Glaucoma Australia’s work with Specsavers is helping to improve quality of care for patients with glaucoma |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Day 1: Vitreoretinal Emergencies |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 2: Diabetes and eye health: KeepSight – a national diabetes eye screening reminder program |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Day 2: Interpretation of OCT in Diabetes and Age-related Macular Degeneration |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| No |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 1: Managing corneal and anterior eye conditions |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Day 2: Optometric management of ocular inflammation |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/
Supplier? | Points for attending &
Passing Assessment |
|---|
| Day 2: Transforming Eye Health | Face to Face without Assessment | No | No | 1.00 |
| Day 2: Diabetic Retinopathy Screening | Face to Face with Assessment | No | No | 3.00 |
| Day 2: Diabetic Retinopathy Screening | Face to Face with Assessment | No | No | 3.00 |
| Day 1: Optometric management of paediatric conditions | Face to Face with Assessment | No | No | 3.00 |
| Day 2: Glaucoma co-management and the Ophthalmology Local Education and Engagement Program | Face to Face with Assessment | Yes | No | 3.00 |
| Day 1: Glaucoma diagnosis and management | Face to Face with Assessment | Yes | No | 3.00 |
| Day 2: Decoding the Alphabet Soup of Ocular Oncology | Face to Face with Assessment | No | No | 3.00 |
| Day 1: Adaptive Technology and Low Vision Patients | Face to Face with Assessment | No | No | 1.00 |
| Day 1: Integrated patient support for patients at risk or living with macular disease | Face to Face with Assessment | No | No | 1.00 |
| Day 2: How Glaucoma Australia’s work with Specsavers is helping to improve quality of care for patients with glaucoma | Face to Face with Assessment | No | No | 1.00 |
| Day 1: Vitreoretinal Emergencies | Face to Face with Assessment | No | No | 3.00 |
| Day 2: Diabetes and eye health: KeepSight – a national diabetes eye screening reminder program | Face to Face with Assessment | No | No | 1.00 |
| Day 2: Interpretation of OCT in Diabetes and Age-related Macular Degeneration | Face to Face with Assessment | No | No | 3.00 |
| Day 1: Managing corneal and anterior eye conditions | Face to Face with Assessment | Yes | No | 3.00 |
| Day 2: Optometric management of ocular inflammation | Face to Face with Assessment | Yes | No | 3.00 |